Johanna Friedl-Naderer
Chief Commercial Officer · Dyne Therapeutics, Inc.
- 2024
- Sep 8, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Johanna Friedl-Naderer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Dirk Kersten - $38.57M in DYN purchases and sales in the last 12 months
- John Cox - $444K in DYN purchases and sales in the last 12 months
- Brian S. Posner - $315K in DYN purchases and sales in the last 12 months
- Douglas Kerr - $233K in DYN purchases and sales in the last 12 months
- Erick Lucera - $229K in DYN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Johanna Friedl-Naderer?
Johanna Friedl-Naderer is a corporate insider, tracked as Chief Commercial Officer of Dyne Therapeutics, Inc. (DYN). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Johanna Friedl-Naderer submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Johanna Friedl-Naderer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($57K) across all tracked filings.
